Ulcerative Colitis (UC) is a chronic inflammatory bowel disease that affects the colon and rectum. For patients with moderate to severe UC, infusion therapy offers targeted biologic treatments to manage symptoms and promote mucosal healing.
Ulcerative Colitis (UC) is a chronic inflammatory bowel disease that affects the colon and rectum. For patients with moderate to severe UC, infusion therapy offers targeted biologic treatments to manage symptoms and promote mucosal healing.
Infusion therapy may be prescribed for RA patients who:
Remicade® (infliximab)
Anti-TNF biologic for moderate to severe UC
Entyvio® (vedolizumab)
Targets gut-selective inflammation
Stelara® (ustekinumab)
IV induction followed by subcutaneous maintenance
Getting Started
All UC patients must be referred by a gastroenterologist or primary care physician.